Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.59 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL5349904 | 0.98 | MAOB (0.58) | MAOBACHEALDH1A1CA1CA2 | |
| SCHEMBL8008145 | 0.98 | — | — | |
| SCHEMBL29374752 | 0.98 | — | — | |
| SCHEMBL156145 | 0.98 | — | — | |
| Ammonia Solution, Strong SCHEMBL27895478 | 0.95 | MAOB (0.59) | MAOBACHEALDH1A1CA1CA2 | |
| Bromide SCHEMBL4665378 | 0.93 | MAOB (0.58) | MAOBACHEALDH1A1CA1CA2 | |
| Hydrochloric Acid SCHEMBL27560881 | 0.93 | MAOB (0.58) | MAOBACHEALDH1A1CA1CA2 | |
| Cyanide SCHEMBL27586511 | 0.91 | MAOB (0.56) | MAOBACHEALDH1A1CA1CA2 | |
| Ethane SCHEMBL27513340 | 0.91 | MAOB (0.56) | MAOBACHEALDH1A1CA1CA2 | |
| SCHEMBL27580985 | 0.87 | MAOB (0.57) | MAOBACHEALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 365 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115260043-B | Synthesis method of meta-hydroxylamine bitartrate | 海南长春花药业有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-115701422-A | Preparation method of KGP94 | 中国科学院昆明植物研究所 | 2023-02-10 | — | — | CN | claimed |
| CN-115260043-A | Synthesis method of meta-hydroxylamine bitartrate | 海南长春花药业有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-114436790-A | Synthesis method of 6-methoxy-1-tetralone | 浙江仙居君业药业有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-101265201-B | Method for synthesizing tramadol hydrochloride | UNIV ZHEJIANG TECHNOLOGY | 2011-11-23 | — | — | CN | claimed |
| CN-100548950-C | Process for preparing esters and ethers of probucol and derivatives thereof | ATHEROGENICS INC (US) | 2009-10-14 | — | — | CN | claimed |
| US-7470816-B2 | Tramadol recovery process | IPAC LABORATORIES LIMITED (IN) | 2008-12-30 | — | — | US | claimed |
| CN-101265201-A | Method for synthesizing tramadol hydrochloride | UNIV ZHEJIANG TECHNOLOGY (CN) | 2008-09-17 | — | — | CN | claimed |
| US-20070112074-A1 | Tramadol recovery process | IPCA LABORATORIES LIMITED (IN) | 2007-05-17 | — | — | US | claimed |
| EP-1785412-A1 | Tramadol recovery process | IPCA Laboratories Limited (IN) | 2007-05-16 | — | — | EP | claimed |
| CN-1759084-A | Process for preparing esters and ethers of probucol and derivatives thereof | ATHEROGENICS INC (US) | 2006-04-12 | — | — | CN | claimed |
| WO-2025137310-A1 | CRYSTALLINE GPR40 AGONIST AND METHODS OF MAKING | KALLYOPE, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| EP-4565588-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | Suzhou Keen Therapeutics Co., Ltd. (CN) | 2025-06-11 | — | — | EP | disclosed |
| CN-118955473-A | Difunctional compounds for degrading BTK via the ubiquitin proteasome pathway | 紐力克斯治疗公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118382610-A | DHODH inhibitors containing carboxylic acid bioisosteres | 埃慕尼克股份公司 | 2024-07-23 | — | — | CN | disclosed |
| US-4387097-A | Morpholines | JOHN WYETH AND BROTHER LIMITED (GB) | 1983-06-07 | — | — | US | disclosed |
| EP-0061712-A1 | Antiinflammatory and/or analgesic 1,8-dihydro (or 3,8-dihydro)-8-aryl-2-((substituted)thio)-indeno(1,2-)imidazoles and their corresponding sulfoxides and sulfones | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-10-06 | — | — | EP | disclosed |
| EP-0061899-A1 | Morpholines | JOHN WYETH & BROTHER LIMITED (GB) | 1982-10-06 | — | — | EP | disclosed |
| US-4301164-A | FOR USE AS ANTIULCER AGENTS, HYPOTENSIVE AGENTS, ANTITHROMBOSIC AGENTS | TORAY INDUSTRIES, INC. (JP) | 1981-11-17 | — | — | US | disclosed |
| EP-0024943-A1 | 5,6,7-Trinor-4,8-inter-m-phenylene PGI2 derivatives and pharmaceutical compositions containing them | TORAY INDUSTRIES, INC. (JP) | 1981-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112074-A1 | Tramadol recovery process | TRAM1, OPRK1, SLC6A6 | MAOB 921/4885ACHE 894/4885ALDH1A1 1251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.